Poly ICLC
From Wikipedia, the free encyclopedia
| Combination of | |
|---|---|
| Carboxymethylcellulose | |
| Polyinosinic-polycytidylic acid | |
| Poly-L-lysine double-stranded RNA | |
| Clinical data | |
| Legal status | ? |
| Identifiers | |
| ATC code | L03AX08 |
 (what is this?) (verify) | |
Poly ICLC is an immunostimulant.
It consists of carboxymethylcellulose, polyinosinic-polycytidylic acid, and poly-L-lysine double-stranded RNA.[1]
It is a ligand for toll like receptor-3.[2]
References
- ↑ "Definition of poly ICLC - National Cancer Institute Drug Dictionary". Retrieved 2007-11-13.
- ↑ Zhu X, Nishimura F, Sasaki K, et al. (2007). "Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models". Journal of translational medicine 5: 10. doi:10.1186/1479-5876-5-10. PMC 1802742. PMID 17295916.
External links
- National Cancer Institute: poly ICLC
| |||||||||||||||||||||||||||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.